You’ve probably heard of alopecia, a fairly common hair condition, but did you know that many of its symptoms are harder to ...

Incyte filed a lawsuit to try to block the launch of Leqselvi, claiming that the drug infringed a US patent (No. 9,662,335) ...

The effectiveness of these supplements varies for genetic and autoimmune hair loss. Consistent supplementation is key for ...

Alopecia areata is linked to genetic, environmental, and immune factors, with associations to atopy, allergies, and hypothyroidism. Mendelian randomization identified genetic links between trace ...

Eli Lilly and Incyte's Olumiant has secured the first FDA approval for a systemic drug to treat alopecia areata, an autoimmune condition causing patchy hair loss that affects more than 700,000 ...

Hair loss tends to progressively get worse. Alopecia areata. This is an autoimmune disease that causes hair loss. You might notice round bald patches on your scalp or hair loss in other places on ...

Does anyone else? Cracking farcical jokes about alopecia is ableist misogynoir at its finest. As an autoimmune disorder that causes hair loss, alopecia is not simply an aesthetic difference ...

Alopecia areata was more likely to develop in patients with inflammatory bowel disease (IBD) who were taking anti–tumor necrosis factor (TNF) therapy at the onset of the condition.

Despite winning an alopecia areata approval for its drug Leqselvi in July, Sun Pharma will have to wait a while longer to ...